Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 7, 2012, Pages 2573-2578

  Pica, Natalie ^a   Hai, Rong ^a   Krammer, Florian ^a   Wang, Taia T ^a   Maamary, Jad ^a   Eggink, Dirk ^a   Tan, Gene S ^a   Krause, Jens C ^a   Moran, Thomas ^a   Stein, Cheryl R ^a   Banach, David ^a   Wrammert, Jens ^a   Belshe, Robert B ^b   García Sastre, Adolfo ^a,c   Palese, Peter ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cross protection; Cross reactivity; Subtype

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ANIMAL CELL; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; CHILD; CONTROLLED STUDY; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS A H1N1; NONHUMAN; PRIORITY JOURNAL; SEASONAL INFLUENZA; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANTIBODIES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; SEASONS;

ORTHOMYXOVIRIDAE;

EID: 84863115945     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1200039109     Document Type: Article

References (37)

1. Thompson WW, Comanor L, Shay DK (2006) Epidemiology of seasonal influenza: Use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 194(Suppl 2):S82-S91. (Pubitemid 44630951)
2. Johnson NP, Mueller J (2002) Updating the accounts: Global mortality of the 1918-1920 "Spanish"influenza pandemic. Bull Hist Med 76:105-115.
3. Guan Y, et al. (2010) The emergence of pandemic influenza viruses. Protein Cell 1:9-13.
4. World Health Organization (2009) Dr. Margaret Chan: Statement to the Press: World Now at the Start of 2009 Influenza Pandemic. Accessed December 28, 2011. Available at http://www.who.int/mediacentre/news/statements/2009/h1n1- pandemic-phase6-20090611/en/index.html.
5. Palese P, Wang TT (2011) Why do influenza virus subtypes die out? A hypothesis. MBio 2:e00150-11.
6. Palese P, Shaw ML (2006) Fields Virology, eds Knipe D, Howley P (Lippincott Williams & Wilkins, Philadelphia), pp 1648-1689.
7. Okuno Y, Matsumoto K, Isegawa Y, Ueda S (1994) Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains. J Virol 68:517-520.
8. Throsby M, et al. (2008) Heterosubtypic neutralizingmonoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3:e3942.
9. Ekiert DC, et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843-850.
10. Varecková E, Mucha V, Wharton SA, Kostolanský F (2003) Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies. Arch Virol 148:469-486.
11. Wrammert J, et al. (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208:181-193.
12. Corti D, et al. (2010) Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 120:1663-1673.
13. Wang TT, et al. (2010) Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 6:e1000796.
14. Sui J, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16:265-273.
15. Ekiert DC, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
16. Wei CJ, et al. (2010) Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060-1064.
17. Kashyap AK, et al. (2010) Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog 6:e1000990.
18. Corti D, et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856.
19. Steel J, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1:1.
20. Okuno Y, Isegawa Y, Sasao F, Ueda S (1993) A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67:2552-2558. (Pubitemid 23118850)
21. Wang TT, et al. (2010) Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci USA 107:18979-18984.
22. Schulman JL, Kilbourne ED (1969) Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: Distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci USA 63:326-333.
23. Kashyap AK, et al. (2008) Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci USA 105:5986-5991. (Pubitemid 351758386)
24. Pearce MB, Belser JA, Houser KV, Katz JM, Tumpey TM (2011) Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets. Vaccine 29:2887-2894.
25. Kostolanský F, Mucha V, Slováková R, Varecková E (2002) Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide. Acta Virol 46:229-236.
26. Chen GL, Lau YF, Lamirande EW, McCall AW, Subbarao K (2011) Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proc Natl Acad Sci USA 108:1140-1145.
27. Kim JH, Skountzou I, Compans R, Jacob J (2009) Original antigenic sin responses to influenza viruses. J Immunol 183:3294-3301.
28. Wang TT, Palese P (2011) Biochemistry. Catching a moving target. Science 333:834-835.
29. Davenport FM, Hennessy AV, Francis T, Jr. (1953) Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 98:641-656.
30. Manicassamy B, et al. (2010) Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 6:e1000745.
31. Skountzou I, et al. (2010) Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 185:1642-1649.
32. Hai R, et al. (2008) Influenza B virus NS1-truncated mutants: Live-attenuated vaccine approach. J Virol 82:10580-10590. (Pubitemid 352691164)
33. Fodor E, et al. (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73:9679-9682. (Pubitemid 29487131)
34. Quinlivan M, et al. (2005) Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79:8431-8439. (Pubitemid 40853545)
35. Meier S, Güthe S, Kiefhaber T, Grzesiek S (2004) Foldon, the natural trimerization domain of T4 fibritin, dissociates into a monomeric A-state form containing a stable beta-hairpin: Atomic details of trimer dissociation and local beta-hairpin stability from residual dipolar couplings. J Mol Biol 344:1051-1069. (Pubitemid 39491249)
36. Evans MJ, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805. (Pubitemid 46582027)
37. Tscherne DM, Manicassamy B, García-Sastre A (2010) An enzymatic virus-like particle assay for sensitive detection of virus entry. J Virol Methods 163:336-343.